Sleep Number (SNBR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
23 Dec, 2025Executive summary
Net sales for Q1 2025 were $393 million, down 16% year-over-year due to lower volume and reduced store count.
Leadership transition with a new CEO focused on stabilizing and transforming the business for sustainable growth and shareholder returns, including a major organizational redesign that reduced corporate management by 21%.
Operating expenses reduced by $23–$32 million year-over-year before restructuring and non-recurring costs, mainly from lower marketing and selling expenses.
Adjusted EBITDA was $22 million, down from $37 million year-over-year, with margin declining 230 basis points to 5.6%.
Net loss was $8.6–$9 million (about $0.38 per diluted share), compared to $7–$7.5 million in the prior year.
Financial highlights
Gross profit margin expanded to 61.2%, up 250 basis points year-over-year, mainly due to product cost reductions, favorable mix, and logistics efficiencies.
Gross profit was $241 million, a decrease of $36 million year-over-year.
Operating expenses (excluding restructuring/one-time costs) were $237 million, a 9% improvement year-over-year.
Free cash flow was a use of $7–$7.2 million, down $32 million year-over-year.
Leverage ratio stood at 4.46x–4.5x EBITDA, within covenant maximum of 4.75x.
Outlook and guidance
No full-year 2025 guidance provided due to leadership transition, macroeconomic uncertainty, and evolving consumer sentiment; guidance will be reassessed as the new team evaluates strategy and demand.
Expect continued top-line pressure in the near term; cost structure prepared for stagnant demand.
Gross margin improvements expected to be maintained, though tariffs could pressure margins by ~100 basis points.
$80–$100 million in annualized cost reductions targeted, with immediate impact in Q2 and further benefits in the second half of the year.
Additional $10–$15 million in restructuring costs expected through the remainder of 2025, primarily for severance, contract termination, and asset impairment.
Latest events from Sleep Number
- Proxy seeks board declassification, equity plan expansion, and governance modernization.SNBR
Proxy filing24 Mar 2026 - Turnaround strategy and cost reductions set the stage for growth and free cash flow in 2026.SNBR
Investor presentation12 Mar 2026 - Cost savings and new products drive turnaround, setting up double-digit EBITDA growth for 2026.SNBR
Q4 202512 Mar 2026 - Gross margin and cost improvements offset sales declines, supporting full-year EBITDA guidance.SNBR
Q2 20242 Feb 2026 - Gross margin hit a three-year high as cost cuts offset a 10% sales decline in Q3.SNBR
Q3 202417 Jan 2026 - Major transformation underway with cost cuts, new products, and a focus on value-driven growth.SNBR
28th Annual ICR Conference 202613 Jan 2026 - Transformation plan targets growth, efficiency, and strong free cash flow in 2026.SNBR
Investor presentation13 Jan 2026 - Gross margin gains and cost cuts drove Q4 EBITDA up 43% despite double-digit sales declines.SNBR
Q4 202425 Dec 2025 - Board proposes governance reforms, new CEO, and equity plan changes amid industry headwinds.SNBR
Proxy Filing1 Dec 2025